SCHEDULE: RA Capital Exits Adagio Medical Holdings Stake

Sentiment:

Beneficial Ownership Amendment


RA Capital Management and its affiliates have fully divested their beneficial ownership in Adagio Medical Holdings, Inc., reducing their stake to 0.0%.

Worse than expectedA major institutional investor, RA Capital Management, and its affiliates have completely divested their 0.0% beneficial ownership in Adagio Medical Holdings, Inc., signaling a significant loss of institutional support.

Summary

  • RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (collectively, the "Reporting Persons") have reported 0.0% beneficial ownership of Adagio Medical Holdings, Inc. common stock.
  • This filing is Amendment No. 3 to a Schedule 13G, indicating a complete divestment from a previously held position.
  • The event requiring this filing occurred on June 30, 2025, with the filing submitted on August 14, 2025.

Sentiment

Score: 2

Explanation: The complete divestment by a major institutional investor like RA Capital Management is a strong negative signal, indicating a lack of confidence or a strategic exit from the company.

Negatives

  • The complete divestment of beneficial ownership by RA Capital Management and its affiliates, reducing their stake to 0.0%, indicates a significant institutional investor has exited their position in Adagio Medical Holdings, Inc.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investor's complete exit from Adagio Medical Holdings, Inc., which can be interpreted by the market as a loss of confidence or a strategic portfolio reallocation within the healthcare sector.

Stakeholder Impact

  • Shareholders may experience negative sentiment and potential share price decline due to the complete divestment by a significant institutional investor.

Key Dates

DateDescription
06/30/2025Date of event requiring the filing of this statement, indicating the point at which beneficial ownership fell to 0.0%.
08/14/2025Date the Schedule 13G Amendment No. 3 was signed and filed.

Recommendation

strong sell

The complete divestment of a significant stake by a prominent institutional investor like RA Capital Management is a highly negative indicator. It suggests that a sophisticated investor has lost conviction in the company's future prospects or has identified significant risks, prompting a full exit. This action typically signals a lack of confidence and could lead to further downward pressure on the stock price, making a 'strong sell' recommendation appropriate for investors.

Keywords

Adagio Medical Holdings, RA Capital Management, Schedule 13G, beneficial ownership, institutional investor, common stock, divestment, healthcare

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.